VRTX
Valuation Healthcare · Biotechnology Data as of 2025-12-31P/E Ratio · Metrics
P/E Ratio
24.37
PEG Ratio
0.30
Dividend Yield
-
Gross Margin
85.56%
Net Margin
36.91%
Revenue CAGR 3Y
11.91%
ROE
25.52%
ROA
18.22%
Buyback Yield
0.58%
Current Ratio
2.90
Magic Earn Yield
4.53%
Altman Z-Score
10.67
Fair Value River
Score
Valuation 57
Profitability 71
Growth 40
Health 98
Yield 10